PYRO-ENERGEN Treatment Against Alzheimer's Disease
Are you suffering from Alzheimer's disease? PYRO-ENERGEN is the answer.
Alzheimer's disease is a degenerative disorder that affects the brain and causes dementia (cognitive and intellectual deterioration), especially in late life. It was named after Alois Alzheimer (1864-1915), a German neurologist who described it in 1907.
However, I believe that Alzheimer's disease has existed in various forms since the beginning of human existence. The disease does not only affect the elderly but can occur at any age, from young to old.
Symptoms of Alzheimer's disease vary widely, and some may not be noticeable, especially in young children and teens. Although Alzheimer's disease is not a normal part of the aging process, the risk of developing the disease increases as people grow older.
Alzheimer's disease takes a devastating toll, not only on the patients but also on those who love and care for them. Some patients experience immense fear and frustration as they struggle with once commonplace tasks and slowly lose their independence. Family, friends, and especially those who provide daily care suffer immeasurable pain and stress as they witness Alzheimer's disease slowly take their loved ones from them.
The onset of Alzheimer's disease is usually very gradual. In the early stages, Alzheimer's patients have relatively mild problems learning new information and remembering where they have left common objects, such as keys or a wallet. In time, they begin to have trouble recollecting recent events and finding the right words to express themselves. As the disease progresses, patients may have difficulty remembering what day or month it is, or finding their way around familiar surroundings. They may develop a tendency to wander off and then be unable to find their way back. Patients often become irritable or withdrawn as they struggle with fear and frustration when once commonplace tasks become unfamiliar and intimidating. Behavioral changes may become more pronounced as patients become paranoid or delusional and unable to engage in normal conversation.
Doctors and scientists claim that brains of patients with Alzheimer's have distinctive formations, abnormally shaped proteins called tangles and plaques that are recognized as the hallmark of the disease, and these are related to memory. Tangles are long, slender tendrils found inside nerve cells, or neurons. Scientists have learned that when a protein called tau becomes altered, it may cause the characteristic tangles in the brain of an Alzheimer's patient. In healthy brains, tau provides structural support for neurons, but in Alzheimer's patients this structural support collapses.
According to my study, this is not true. These distinctive formations of proteins are byproducts caused by the negative energy force from the outer surface of the body. Furthermore, my research indicates that having a family history of Alzheimer's disease does not necessarily increase the likelihood of developing the disease.
The causes of Alzheimer's disease remain a mystery among doctors and scientists of the world. According to doctors, Alzheimer's disease can only be positively diagnosed by examining brain tissue under a microscope to observe the hallmark plaques and tangles, which is only possible after a patient's death.
Isn't this a crazy way of diagnosis? As I mentioned previously, the hallmark plaques and tangles are just byproducts. Shouldn't we focus on preventing the formation of these byproducts before the disease takes hold? Physicians rely on a series of other techniques to diagnose probable Alzheimer's disease in living patients. The physician also asks about the patient's family medical history to learn about any past serious illnesses, which may provide a clue about the patient's current symptoms. But as I mentioned earlier, the disease is actually caused by the negative energy.
According to the physicians I know, there is no known cure for Alzheimer's disease, and treatment focuses on lessening symptoms and attempting to slow the course of the disease. Drugs that increase or improve the function of brain acetylcholine, the neurotransmitter that affects memory, have been approved by the United States Food and Drug Administration (FDA) for the treatment of Alzheimer's disease. Called acetylcholinesterase inhibitors, these drugs have had modest but clearly positive effects on the symptoms of the disease. These drugs can benefit patients at all stages of illness, but they are particularly effective in the middle stage. This finding corresponds with new evidence that low acetylcholine levels in patients with Alzheimer's disease may not be present in the earliest stage of the illness. Evidence shows that there is inflammation in the brains of Alzheimer's patients, which may be associated with the production of amyloid precursor protein. Studies are still underway by scientists of the world.